NO159267C - Fremgangsmaate for spalting av en racemisk modifikasjon avbeta-adrenerge aryl- eller hetaryloksypropanolaminer. - Google Patents

Fremgangsmaate for spalting av en racemisk modifikasjon avbeta-adrenerge aryl- eller hetaryloksypropanolaminer.

Info

Publication number
NO159267C
NO159267C NO833254A NO833254A NO159267C NO 159267 C NO159267 C NO 159267C NO 833254 A NO833254 A NO 833254A NO 833254 A NO833254 A NO 833254A NO 159267 C NO159267 C NO 159267C
Authority
NO
Norway
Prior art keywords
hetaryloxypropanolamines
divolution
debeta
addrenge
aryl
Prior art date
Application number
NO833254A
Other languages
English (en)
Norwegian (no)
Other versions
NO159267B (no
NO833254L (no
Inventor
Ronald D Dennis
Terence M Dolak
William E Kreighbaum
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO833254L publication Critical patent/NO833254L/no
Priority to NO88881179A priority Critical patent/NO168638C/no
Publication of NO159267B publication Critical patent/NO159267B/no
Publication of NO159267C publication Critical patent/NO159267C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO833254A 1982-09-13 1983-09-12 Fremgangsmaate for spalting av en racemisk modifikasjon avbeta-adrenerge aryl- eller hetaryloksypropanolaminer. NO159267C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO88881179A NO168638C (no) 1982-09-13 1988-03-17 Urinstoffderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/417,794 US4463176A (en) 1982-09-13 1982-09-13 Process for resolution of optical isomers

Publications (3)

Publication Number Publication Date
NO833254L NO833254L (no) 1984-03-14
NO159267B NO159267B (no) 1988-09-05
NO159267C true NO159267C (no) 1988-12-14

Family

ID=23655420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833254A NO159267C (no) 1982-09-13 1983-09-12 Fremgangsmaate for spalting av en racemisk modifikasjon avbeta-adrenerge aryl- eller hetaryloksypropanolaminer.

Country Status (29)

Country Link
US (1) US4463176A (cs)
JP (2) JPS5980616A (cs)
KR (1) KR890000616B1 (cs)
AT (1) AT385032B (cs)
AU (1) AU573535B2 (cs)
BE (1) BE897737A (cs)
CA (1) CA1250290A (cs)
CH (1) CH660732A5 (cs)
CY (1) CY1543A (cs)
DE (1) DE3333025A1 (cs)
DK (2) DK172720B1 (cs)
ES (1) ES525543A0 (cs)
FI (1) FI83767C (cs)
FR (1) FR2540490B1 (cs)
GB (2) GB2127020B (cs)
GR (1) GR81546B (cs)
HK (1) HK97990A (cs)
HU (1) HU193183B (cs)
IE (1) IE55650B1 (cs)
IL (1) IL69708A (cs)
IT (1) IT1170213B (cs)
LU (1) LU84998A1 (cs)
NL (1) NL8303154A (cs)
NO (1) NO159267C (cs)
NZ (1) NZ205554A (cs)
PT (1) PT77331B (cs)
SE (2) SE452608B (cs)
YU (1) YU43327B (cs)
ZA (1) ZA836795B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
US5364872A (en) * 1984-04-16 1994-11-15 Yamanouchi Pharmaceutical Co., Ltd. Dihydropyridine-3,5-dicarboxylic acid ester derivatives
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
US4797498A (en) * 1986-07-18 1989-01-10 Pennwalt Corporation Flavonoxypropanolamines and esters of flavonoxypropanolamines as antiarrhythmic agents
WO1988007044A1 (en) * 1987-03-17 1988-09-22 Insite Vision, Inc. Timolol derivatives
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
US4806660A (en) * 1987-11-06 1989-02-21 Pennwalt Corporation Aurone oxypropanolamines
JP2801768B2 (ja) * 1990-11-17 1998-09-21 日東電工株式会社 新規な光学活性メトプロロール・酒石酸誘導体塩及びその製法、並びにこの塩を用いる光学活性メトプロロールの製法
US5082970A (en) * 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
KR100332399B1 (ko) * 1999-02-22 2002-04-13 김경호 메토프롤롤 라세미체로부터 메토프롤롤 에난티오머의 제조방법
BE1012622A3 (fr) 1999-04-21 2001-01-09 Solvay Procede pour la separation d'enantiomeres et reactif enantiopur.
US7138538B2 (en) * 2000-04-14 2006-11-21 Solvay (Societe Anonyme) Process for the separation of enantiomers and enantiopure reagent
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
PL3911648T3 (pl) 2019-01-18 2025-03-10 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234595A (en) * 1880-11-16 Juan f
GB1211589A (en) * 1968-08-06 1970-11-11 Ici Ltd Enantiomer isolation process
BE786963A (fr) * 1971-07-30 1973-01-29 Degussa Procede pour le dedoublement racemique de d,1-phenylpropanolamine
US4234595A (en) * 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
JPS5770884A (en) * 1980-10-21 1982-05-01 Kyowa Hakko Kogyo Co Ltd Novel piperidine derivative and its preparation
FI76551C (fi) * 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.

Also Published As

Publication number Publication date
NO159267B (no) 1988-09-05
AT385032B (de) 1988-02-10
NO833254L (no) 1984-03-14
JP2759184B2 (ja) 1998-05-28
YU184683A (en) 1986-02-28
JPH0414086B2 (cs) 1992-03-11
IE55650B1 (en) 1990-12-05
DK416483D0 (da) 1983-09-13
KR840005998A (ko) 1984-11-21
CA1250290A (en) 1989-02-21
GB2127020A (en) 1984-04-04
GR81546B (cs) 1984-12-11
SE452608B (sv) 1987-12-07
DE3333025C2 (cs) 1992-01-23
IL69708A (en) 1987-02-27
GB8324536D0 (en) 1983-10-12
CH660732A5 (fr) 1987-06-15
LU84998A1 (fr) 1984-04-24
ZA836795B (en) 1984-04-25
DK172732B1 (da) 1999-06-21
DK172720B1 (da) 1999-06-14
BE897737A (fr) 1984-03-12
GB2169294B (en) 1987-05-13
FI833270L (fi) 1984-03-14
KR890000616B1 (ko) 1989-03-22
PT77331B (en) 1986-08-28
SE8602724L (sv) 1986-06-18
ATA326383A (de) 1987-07-15
JPH0859597A (ja) 1996-03-05
YU43327B (en) 1989-06-30
FI833270A0 (fi) 1983-09-13
SE8602724D0 (sv) 1986-06-18
SE8304887D0 (sv) 1983-09-12
HK97990A (en) 1990-11-30
GB2169294A (en) 1986-07-09
FI83767C (fi) 1991-08-26
FR2540490A1 (fr) 1984-08-10
NL8303154A (nl) 1984-04-02
IL69708A0 (en) 1983-12-30
NZ205554A (en) 1987-09-30
ES8504104A1 (es) 1985-04-16
HU193183B (en) 1987-08-28
FR2540490B1 (fr) 1986-09-05
DE3333025A1 (de) 1984-03-29
IE832134L (en) 1984-03-13
GB8604515D0 (en) 1986-04-03
PT77331A (en) 1983-10-01
DK416483A (da) 1984-03-14
US4463176A (en) 1984-07-31
IT1170213B (it) 1987-06-03
CY1543A (en) 1991-03-22
DK106897A (da) 1997-09-17
GB2127020B (en) 1987-05-07
JPS5980616A (ja) 1984-05-10
AU1908183A (en) 1984-03-22
AU573535B2 (en) 1988-06-16
FI83767B (fi) 1991-05-15
SE8304887L (sv) 1984-03-14
IT8322852A0 (it) 1983-09-12
ES525543A0 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
NO159267C (no) Fremgangsmaate for spalting av en racemisk modifikasjon avbeta-adrenerge aryl- eller hetaryloksypropanolaminer.
NO166218C (no) Fremgangsmaate for hydrolysering av cos.
NO813726L (no) Fremgangsmaate for fremstilling av piperazinyl-benzo-heterocykliske forbindelser
FI803851L (fi) Anordning foer bestaemning av vindenergin foer reglering av vindkraftverk
NO832616L (no) Fremgangsmaate for fremstilling av et dihydroerytromycin-derivat
NO156713C (no) Fremgangsmaate for fremstilling av antikariestyggegummi.
NO812977L (no) Fremgangsmaate for fremstilling av mikrokapsler
NO165844C (no) Fremgangsmaate for nedbygging av alfa-olefin-polymerer.
NO166133C (no) Analogifremgangsmaate for fremstilling av ((bis(aryl)metylen)-1-piperidinyl)-alkylpyrimidinoner.
DE3382773D1 (de) Arylnitrone.
ES522325A0 (es) Un compuesto de pirazolpiridina.
NO157537C (no) Fremgangsmaate for fremstilling av tioetere.
FI833648A0 (fi) Foerfarande foer framstaellning av 4-metyl-5-alkyltiometylimidazoler
FI833868A0 (fi) Anordning foer daempning av en slagbelastning
NO833962L (no) Fremgangsmaate ved stabilisering av leireholdig jord
ES520013A0 (es) Un procedimiento de fabricacion de elementos refractarios.
DE3382382D1 (de) Herstellungsverfahren von cephalosporinverbindungen.
FI831814A0 (fi) Anordning foer bearbetning av traedbark
FI813798L (fi) Foerfarande foer avlaegsnande av en belaeggning av antrakinon
NO154639C (no) Fremgangsmaate for fremstilling av en fiskegarnknute.
NO162816C (no) Fremgangsmaate for fremstilling av et dialkanolyksybenzylidendialkanoat.
FI824411L (fi) Foerfarande foer framstaellning av 1- isopropylamino-3-aryloxi-2-propanoler.
FI830485L (fi) Anordning foer taeckning av en lastbehaollare
NO823440L (no) Fremgangsmaate for fremstilling av et nytt isopropylamino-pyrimidin-derivat.
TR21803A (tr) Atese dayanikh krommagnezi ueruenlerinin ueretilmesine mahsus usul

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN SEPTEMBER 2003